UK markets open in 2 hours 51 minutes
  • NIKKEI 225

    26,728.50
    -80.87 (-0.30%)
     
  • HANG SENG

    26,686.54
    -41.96 (-0.16%)
     
  • CRUDE OIL

    46.38
    +0.74 (+1.62%)
     
  • GOLD FUTURES

    1,844.10
    +3.00 (+0.16%)
     
  • DOW

    29,969.52
    +85.73 (+0.29%)
     
  • BTC-GBP

    14,364.07
    +48.29 (+0.34%)
     
  • CMC Crypto 200

    379.19
    +4.79 (+1.28%)
     
  • ^IXIC

    12,377.18
    +27.82 (+0.23%)
     
  • ^FTAS

    3,672.88
    +21.56 (+0.59%)
     

Global Skincare Devices Market (2020 to 2030) - by Product, Distribution Channel, Application and End-user

Research and Markets
·11-min read

Dublin, Nov. 20, 2020 (GLOBE NEWSWIRE) -- The "Skincare Devices Market Research Report: By Product, Distribution Channel, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The International Society of Aesthetic Plastic Surgery (ISAPS) says that in 2018, 10,607,227 surgical cosmetic procedures were performed around the world. Due to the rising demand for aesthetic procedures, the global skincare devices market is predicted to grow to $28,157.2 million by 2030 from $9,531.9 million in 2019, at a healthy 11.0% CAGR between 2020 and 2030, according to the publisher.

Similarly, the volume of non-surgical aesthetic procedures, such as calcium hydroxylapatite, botulinum toxin, poly-L-lactic acid, and hyaluronic acid treatments; non-surgical photorejuvenation and skin tightening procedures, chemical peel, non-surgical fat reduction, and cellulite reduction, is also rising. In particular, the skincare devices market is being propelled by the rising demand for breast lift, breast augmentation, neck lift, fat grafting (face), and brow lift procedures.

The lockdowns implemented in the wake of the COVID-19 pandemic have forced skincare device manufacturers to suspend manufacturing and sales operations, thus leading to low availability of such products. In addition, the skincare devices market advance is also being currently hampered by the closure of cosmetic centers and dermatology clinics and most non-critical hospital departments, both to avoid unnecessary human-human contact and divert the available healthcare resources to COVID care.

In the coming years, the skin tightening & body contouring category is expected to advance with the highest CAGR in the skincare devices market, of 11.8%, under segmentation by application. On account of the increasing volume of liposuction procedures and incidence of obesity, a rising number of people are suffering from loose skin. The ISAPS says that from 1,372,901 in 2014, the number of liposuction surgeries performed around the globe surged to 1,573,680 in 2017 and 1,732,620 in 2018.

The dermatology clinics category would continue dominating the skincare devices market in the immediate future, under the end user segment. Since dermatology clinics are dedicated to skincare, they use the related devices in large numbers, for skin rejuvenation, hair removal, skin tightening, and other purposes.

The highest revenue in the skincare devices market in the present time is generated in North America. With the increasing awareness about skincare and appearance and high disposable income of people, the volume of skincare treatments and associated device sales are high in the region. Additionally, skin cancer treatment coverage is provided under the Medicaid and Medicare programs in the U.S., which further results in high device adoption.

Asia-Pacific (APAC) is on the path to growing the fastest in the skincare devices market in the years to come. The population, especially those of the elderly, as well as the prevalence of obesity and dermatological diseases, is increasing in APAC. This has led to a wide adoption of skincare devices for therapeutic and diagnostic purposes, thereby driving the regional market.

The major companies operational in the global skincare devices market are Merz Pharma GmbH & Co. KGaA, Allergan plc, Michelson Diagnostic Ltd., Candela Corporation, PhotoMedex Inc., Lumenis Ltd., Cutera Inc., Alma Lasers Ltd., Panasonic Corporation, Hologic Inc., Beijing Toplaser Technology Co. Ltd., Bausch Health Companies Inc., TRIA Beauty Inc., and Nu Skin Enterprises Inc.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Treatment devices
4.1.1.1.1 Light/LED therapy & photorejuvenation devices
4.1.1.1.2 Liposuction devices
4.1.1.1.3 Electrosurgical devices
4.1.1.1.4 Laser-based devices
4.1.1.1.5 Cryotherapy devices
4.1.1.1.6 Microdermabrasion devices
4.1.1.1.7 Others
4.1.1.2 Diagnostic devices
4.1.1.2.1 Dermatoscopes
4.1.1.2.2 Biopsy devices
4.1.1.2.3 Image-guided systems
4.1.1.2.4 Others
4.1.2 By Distribution Channel
4.1.2.1 Direct
4.1.2.2 Indirect
4.1.3 By Application
4.1.3.1 Cellulite reduction
4.1.3.2 Disease diagnosis & treatment
4.1.3.3 Hair removal
4.1.3.4 Skin tightening & body contouring
4.1.3.5 Skin rejuvenation
4.1.3.6 Others
4.1.4 By End User
4.1.4.1 Dermatology clinics
4.1.4.2 Hospitals
4.1.4.3 Spas & salons
4.1.4.4 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increase in footfall at medical spas
4.2.1.2 Increasing use of home-use skincare devices
4.2.2 Drivers
4.2.2.1 Increasing cases of skin cancer and other skin-related disorders
4.2.2.2 Technological advancements in skincare devices
4.2.2.3 Increasing disposable income leading to rising expenditure on skincare
4.2.2.4 Rising demand for aesthetic procedures
4.2.2.5 Growing geriatric population
4.2.2.6 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Side-effects associated with skincare devices
4.2.3.2 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Rise of medical spas in emerging countries
4.2.4.2 Emerging medical tourism sector
4.3 Porter's Five Forces Analysis
4.3.1 Bargaining Power of Buyers
4.3.2 Bargaining Power of Suppliers
4.3.3 Intensity of Rivalry
4.3.4 Threat of New Entrants
4.3.5 Threat of Substitutes
4.4 Impact of COVID-19
4.4.1 Global Share by Countries
4.4.1.1 Contribution of countries toward global manufacturing output
4.4.2 Contribution of Countries toward Global Export and Import (2019)
4.4.2.1 Top 20 countries by export
4.4.2.2 Top 20 countries by import
4.4.3 Global Scenario of COVID-19 Impact
4.4.4 Global Scenario
4.4.4.1 GDP growth rate (2019)
4.4.4.2 GDP growth rate (2020)
4.4.4.3 GDP growth rate projection for 2021
4.4.5 Assessment of COVID-19 Impact on GDP and Economic Forecast
4.4.6 Assessment of COVID-19 Impact on Workforce across Various Sectors
4.4.7 Impact of COVID-19 on Skincare Devices Market
4.4.7.1 Current scenario
4.4.7.2 Future scenario

Chapter 5. Global Market Size and Forecast
5.1 Overview
5.2 By Product
5.2.1 Treatment Devices Market, by Type
5.2.2 Diagnostic Devices Market, by Type
5.3 By Distribution Channel
5.4 By Application
5.5 By End User
5.6 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Product
6.1.1 Treatment Devices Market, by Type
6.1.2 Diagnostic Devices Market, by Type
6.2 By Distribution Channel
6.3 By Application
6.4 By End User
6.5 By Country
6.5.1 U.S. Skincare Devices Market
6.5.1.1 By product
6.5.1.1.1 Treatment devices market, by type
6.5.1.1.2 Diagnostic devices market, by type
6.5.1.2 By application
6.5.2 Canada Skincare Devices Market
6.5.2.1 By product
6.5.2.1.1 Treatment devices market, by type
6.5.2.1.2 Diagnostic devices Market, by type
6.5.2.2 By application

Chapter 7. Europe Market Size and Forecast
7.1 By Product
7.1.1 Treatment Devices Market, by Type
7.1.2 Diagnostic Devices Market, by Type
7.2 By Distribution Channel
7.3 By Application
7.4 By End User
7.5 By Country
7.5.1 Germany Skincare Devices Market
7.5.1.1 By product
7.5.1.1.1 Treatment devices market, by type
7.5.1.1.2 Diagnostic devices market, by Type
7.5.1.2 By application
7.5.2 U.K. Skincare Devices Market
7.5.2.1 By product
7.5.2.1.1 Treatment devices market, by type
7.5.2.1.2 Diagnostic devices market, by type
7.5.2.2 By application
7.5.3 France Skincare Devices Market
7.5.3.1 By product
7.5.3.1.1 Treatment devices market, by type
7.5.3.1.2 Diagnostic devices market, by type
7.5.3.2 By application
7.5.4 Italy Skincare Devices Market
7.5.4.1 By product
7.5.4.1.1 Treatment devices market, by type
7.5.4.1.2 Diagnostic devices market, by type
7.5.4.2 By application
7.5.5 Spain Skincare Devices Market
7.5.5.1 By product
7.5.5.1.1 Treatment devices market, by type
7.5.5.1.2 Diagnostic devices market, by type
7.5.5.2 By application

Chapter 8. APAC Market Size and Forecast
8.1 By Product
8.1.1 Treatment Devices Market, by Type
8.1.2 Diagnostic Devices Market, by Type
8.2 By Distribution Channel
8.3 By Application
8.4 By End User
8.5 By Country
8.5.1 China Skincare Devices Market
8.5.1.1 By product
8.5.1.1.1 Treatment devices market, by type
8.5.1.1.2 Diagnostic devices market, by type
8.5.1.2 By application
8.5.2 India Skincare Devices Market
8.5.2.1 By product
8.5.2.1.1 Treatment devices market, by type
8.5.2.1.2 Diagnostic devices market, by type
8.5.2.2 By application
8.5.3 Japan Skincare Devices Market
8.5.3.1 By product
8.5.3.1.1 Treatment devices market, by type
8.5.3.1.2 Diagnostic devices market, by type
8.5.3.2 By application

Chapter 9. LATAM Market Size and Forecast
9.1 By Product
9.1.1 Treatment Devices Market, by Type
9.1.2 Diagnostic Devices Market, by Type
9.2 By Distribution Channel
9.3 By Application
9.4 By End User
9.5 By Country

Chapter 10. MEA Market Size and Forecast
10.1 By Product
10.1.1 Treatment Devices, by Type
10.1.2 Diagnostic Devices, by Type
10.2 By Distribution Channel
10.3 By Application
10.4 By End User
10.5 By Country

Chapter 11. Competitive Landscape
11.1 Market Share Analysis of Key Players
11.2 Global Strategic Developments of Key Players
11.2.1 Product Launches and Approvals
11.2.2 Mergers and Acquisitions
11.2.3 Partnerships
11.2.4 Geographical Expansions
11.3 Major Brands of Skin Rejuvenation/Anti-Aging Skincare Devices

Chapter 12. Company Profiles
12.1 Allergan plc
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Merz Pharma GmbH & Co. KGaA
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Candela Corporation
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.4 Michelson Diagnostics Ltd.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.5 Lumenis Ltd.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.6 PhotoMedex Inc.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.7 Alma Lasers Ltd.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.8 Cutera Inc.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.8.3 Key Financial Summary
12.9 Hologic Inc.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.9.3 Key Financial Summary
12.10 Panasonic Corporation
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.11 Bausch Health Companies Inc.
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 Beijing Toplaser Technology Company Limited
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 Nu Skin Enterprises Inc.
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.13.3 Key Financial Summary
12.14 TRIA Beauty Inc.
12.14.1 Business Overview
12.14.2 Product and Service Offerings

Chapter 13. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/csme13

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900